⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program

Official Title: Kentucky LEADS Lung Cancer Survivorship Care Program - Survivors and Caregivers

Study ID: NCT02989974

Conditions

Lung Cancer

Study Description

Brief Summary: The objective of the Kentucky LEADS Lung Cancer Survivorship Care Program is to develop, administer and evaluate the impact of a comprehensive psychosocial survivorship care program for individuals diagnosed with lung cancer and their caregivers to improve lung cancer survivorship and delivery of high-quality lung cancer care. The investigators hypothesize that the Kentucky LEADS Lung Cancer Survivorship Care Program will demonstrate improved quality of life, better symptom control, increased tobacco treatment, and reduced distress among lung cancer survivors and their caregivers.

Detailed Description: The study design is a single-arm clinical trial, or a prospective cohort design, where a longitudinal series of data will be collected from participants. Participants will be consented and asked to complete a baseline questionnaire (PRE) which includes topics measuring quality of life, distress, symptom management, social support, healthy behaviors, demographics and health history. Two similar questionnaires will be administered after exposure to the Survivorship Care Program (POST and FOL). In addition, the consent form requests permission from survivors to collect clinical data from medical records and the Kentucky Cancer Registry regarding diagnosis and treatment for lung cancer. The study will enroll 300 participants, with an estimate of approximately 30 participants enrolled at each site. However, if a participating site enrolls 30 participants and the overall study accrual has not yet been met, the study PI may allow that respective participating site to continue to enroll participants. Study accrual is competitive across participating sites until the overall study accrual has been met.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Kings Daughters Medical Center - Ashland, Ashland, Kentucky, United States

Commonwealth Cancer Center - Danville, Danville, Kentucky, United States

Hardin Memorial Health - Elizabethtown, Elizabethtown, Kentucky, United States

Hazard ARH Regional Medical Center, Hazard, Kentucky, United States

Markey Cancer Center, Lexington, Kentucky, United States

UofL/Brown Cancer Center - Louisville, Louisville, Kentucky, United States

Baptist Health - Madisonville, Madisonville, Kentucky, United States

St. Claire Regional Medical Center - Morehead, Morehead, Kentucky, United States

Owensboro Health, Owensboro, Kentucky, United States

Contact Details

Name: Jamie L Studts, PhD

Affiliation: Professor, University of Kentucky College of Medicine

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: